The Cellular Health Screening Market is witnessing remarkable growth, with its valuation expected to surge from USD 3.18 billion in 2023 to USD 7.85 billion by 2032. This expansion, projected at a CAGR of 10.60% from 2024 to 2032, is driven by increasing awareness regarding cellular health and its critical role in disease prevention and early diagnosis. Technological...